8-K - GT Biopharma, Inc. | StockGist

Current Report Details

Event Type

Delisting

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

3.01

Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On November 20, 2025, GT Biopharma, Inc. (the “Company”) re

Delisting

$1.00$1.0M$1.00

9.01

Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 104 Cover Page Interactive Data File, formatted in Inline XBRL SIGNATURES Pursuant t

Exhibits Only

Exhibits (1)

8-K